Galena Biopharma to Present at the Lazard Capital Markets 9th Annual Healthcare Conference

        Print
| Source: Galena Biopharma

LAKE OSWEGO, Oregon, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and CEO, will present a corporate overview at the Lazard Capital Markets 9th Annual Healthcare Conference. The presentation will take place on Tuesday, November 13, 2012 at 2:30 p.m. EST at The Pierre Hotel in New York, NY.

The presentation will be webcast and available on the Company's website at http://investors.galenabiopharma.com/events.cfm.

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care.  For more information please visit us at www.galenabiopharma.com.

The Galena Biopharma, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10647

Madeline Hatton
Toll free: +1 (855) 855-GALE (4253), ext. 109


or

Remy Bernarda
IR Sense, LLC
+1 (503) 400-6995